BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18618331)

  • 1. Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid.
    Agarwal V; Nazzal S; Khan MA
    Pharm Dev Technol; 2008; 13(4):291-8. PubMed ID: 18618331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymethyacrylate based microparticulates of insulin for oral delivery: preparation and in vitro dissolution stability in the presence of enzyme inhibitors.
    Agarwal V; Reddy IK; Khan MA
    Int J Pharm; 2001 Aug; 225(1-2):31-9. PubMed ID: 11489552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology.
    Ubaidulla U; Khar RK; Ahmad FJ; Tripathi P
    Pharm Dev Technol; 2009; 14(1):96-105. PubMed ID: 18821127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymethacrylate based microparticulates of insulin for oral delivery, part II: solid state characterization.
    Agarwal V; Khan MA; Nazzal S
    Pharmazie; 2008 Feb; 63(2):122-8. PubMed ID: 18380398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
    Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
    Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors of proteolytic enzymes in the treatment of diabetes mellitus].
    Valuev IL; Sytov GA; Valuev LI; Valueva TA; Ul'ianova MV; Platé NA
    Vopr Med Khim; 2001; 47(1):132-9. PubMed ID: 11385995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
    Shi K; Cui F; Yamamoto H; Kawashima Y
    Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
    Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
    Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a colonic release capsule dosage form and the absorption of insulin.
    Kraeling ME; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):199-209. PubMed ID: 1378164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible pegylation of insulin facilitates its prolonged action in vivo.
    Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
    Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudragit S100 entrapped insulin microspheres for oral delivery.
    Jain D; Panda AK; Majumdar DK
    AAPS PharmSciTech; 2005 Sep; 6(1):E100-7. PubMed ID: 16353953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions.
    Kofuji K; Murata Y; Kawashima S
    Int J Pharm; 2005 Oct; 303(1-2):95-103. PubMed ID: 16139972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of ovomucoid isolated from Muscovy duck (Cairina moschata), domestic goose (Anser anser) and domestic duck (Anas platyrhynchos).
    Nicol K; Watson H; Stevens L
    Br Poult Sci; 1997 May; 38(2):217-9. PubMed ID: 9158900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the stability of insulin delivered through a new glucose-responsive polymeric composite membrane.
    Zhang K; Quan C; Huang H; Taulier N; Wu XY
    J Pharm Pharmacol; 2004 May; 56(5):611-20. PubMed ID: 15142338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and study of immobilized insulin].
    Valuev IL; Valuev LI; Sytov GA; Platé NA
    Biokhimiia; 1996 Sep; 61(9):1584-8. PubMed ID: 8998283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of mucoadhesive dosage form containing rosiglitazone maleate.
    Krishna SS; Ray S; Thakur RS
    Pak J Pharm Sci; 2006 Jul; 19(3):208-13. PubMed ID: 16935828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypsin inhibition activity of heat-denatured ovomucoid: a kinetic study.
    Van der Plancken I; Van Remoortere M; Van Loey A; Hendrickx ME
    Biotechnol Prog; 2004; 20(1):82-6. PubMed ID: 14763827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.